Aarti Drugs P/E Ratio

Current P/E Ratio
20.86
Moderate Valuation
High - Growth expectations or overvalued

Aarti Drugs (AARTIDRUGS) P/E ratio is 20.86 (Moderate), EPS (TTM) ₹21.36, current price ₹431.80 on NSE vs historical average P/E of 15.75 (60.0th percentile) — High - Growth expectations or overvalued. Also explore Aarti Drugs stock price data download to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 20.86
Current Price ₹431.80
EPS (TTM) ₹21.36
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 15.75
Historical Range 2.97 - 33.9
Percentile 60.0%

Sector Context

Sector Average 56.92
Sector Median 32.06
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹23.37
Mar 2026 ₹6.05
Jun 2026 ₹5.49

AARTIDRUGS P/E Ratio — Valuation Signal & Historical Context

Aarti Drugs P/E 20.86 vs historical average 15.75, range 2.97–33.9 — signal: Overvalued.

  • Current PE is 32.5% above historical average
  • Trading at discount to sector average PE of 56.92

Aarti Drugs P/E Ratio Historical Trend

AARTIDRUGS annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 20.86 vs historical average 15.75. For live price, revenue and the complete fundamental profile, see AARTIDRUGS screener.

AARTIDRUGS Historical P/E Ratio — EPS, Year-End Price & Valuation

Aarti Drugs annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 20.54 22.18 ₹455.50 NSE Moderate
2024 29.74 16.66 ₹495.40 NSE High
2023 23.23 19.53 ₹453.60 NSE Moderate
2022 30.48 17.87 ₹544.60 NSE High
2021 33.9 21.68 ₹735.00 NSE High
2020 2.97 49.81 ₹147.95 NSE Low
2019 3.04 47.41 ₹143.90 NSE Low
2018 4.37 36.3 ₹158.55 NSE Low
2017 4.62 33.14 ₹153.00 NSE Low
2016 4.57 32.56 ₹148.80 NSE Low

AARTIDRUGS vs Healthcare Peers — P/E Ratio Comparison

Aarti Drugs P/E 20.86 vs Healthcare average 56.92, median 32.06 — range 1.99–747.21.

Sector Average
56.92
Sector Median
32.06
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 1.99 ₹66 Low
Murae Organisor MURAE 2.86 ₹41 Low
Colinz Laboratories COLINZ 3.27 ₹9 Low
Phaarmasia PHRMASI 3.41 ₹59 Low
Sun Pharma Advanced Rese… SPARC 4.03 ₹6,361 Low
Dipna Pharmachem DPL 4.65 ₹12 Low
JFL Life Sciences JFLLIFE 4.95 ₹67 Low
Shelter Pharma SHELTER 5.71 ₹56 Low
GKB Ophthalmics GKB 5.9 ₹33 Low
Kabra Drugs KABRADG 6.29 ₹49 Low